Vasomedical (OTC: VASO) President & CEO Jun Ma, Ph.D., was interviewed by OneMedRadio. Vasomedical is a Westbury, New York device company with a market cap of $39M focusing on cardiac disease.
The 5th Annual OneMedForum San Francisco 2012 is around the corner and builds on the success and recognition of four previous San Francisco Forums and two recently launched in New York City.
Bacterin International Holdings (AMEX:BONE) announced Tuesday it secured a 42 month-long, $15 million credit facility with MidCap Financial LLC and Silicon Valley Bank.
IntelliCell BioSciences, Inc. (OTCQB: SVFC), maker of stromal vascular fraction that contains adipose derived adult stem cells opens new processing center in Houston, Texas.
Keating Capital’s President Timothy Keating was interviewed by OneMedRadio where he describes the liquidity premium that gives public companies 3x valuation over private company peers and the dramatic decline in IPOs and increase in size that is debilitating economic growth.
Novadaq Technologies (TSX:NDQ) President & CEO Arun Menawat, Ph.D was interviewed by OneMedRadio and discusses the roll out of his surgical imaging technology.
Zack’s Investment Research’s Senior Biotech Analyst, Jason Napodano, was interviewed by OneMedRadio where he discussed International Stem Cell Corp [OTC:ISCO].
OneMedPlace (OMP) announced the creation of OneMedRadio to anchor an expansion of coverage on small public companies in the healthcare and life sciences sector.
Bio-Rad Laboratories (NYSE:BIO) announced Monday it received FDA premarket approval for its fourth generation human immunodeficiency virus (HIV) diagnostic test.
Biotech company Ligand Pharmaceuticals Inc. reported Tuesday that its partner GlaxoSmithKline received encouraging results in Hepatitis C study.
Copyright © 2025 | WordPress Theme by MH Themes